Nordwand Advisors’s Allogene Therapeutics ALLO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-1,000	Closed	-$2.33K	–	144
2024 Q2	$2.33K	Buy	+1,000	New	+$2.33K	﹤0.01%	142
2023 Q1	–	Sell	-9,528	Closed	-$59.9K	–	128
2022 Q4	$59.9K	Buy	+9,528	New	+$59.9K	0.01%	62